Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.
about
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypesA highly conserved neutralizing epitope on group 2 influenza A virusesB Cells and Functional Antibody Responses to Combat InfluenzaAdvances in structure-based vaccine designInfluenza virus hemagglutinin stalk-based antibodies and vaccinesTowards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensingAdvancements in the development of subunit influenza vaccinesBroadly neutralizing antibodies against influenza virus and prospects for universal therapiesStructural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccinesStructure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus HemagglutininInhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutininBiogenesis of influenza a virus hemagglutinin cross-protective stem epitopesInfluenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protectionTwo years after pandemic influenza A/2009/H1N1: what have we learned?Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccinesAssessment of influenza virus hemagglutinin stalk-based immunity in ferrets.New vaccines against influenza virus.Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 virusesUniversal influenza vaccines, a dream to be realized soon.Evaluation of antibody response in mice against avian influenza A (H5N1) strain neuraminidase expressed in yeast Pichia pastoris.Continuing challenges in influenza.Advances in influenza vaccination.Adenoviral vectors as novel vaccines for influenza.Emerging influenza viruses and the prospect of a universal influenza virus vaccine.Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitopeA Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin ProteinAn H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 SubtypeProspects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.Novel universal influenza virus vaccine approachesStalking influenza by vaccination with pre-fusion headless HA mini-stemBaculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in MiceMulti-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to InfluenzaCross-protective immunity to influenza A viruses.Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza.A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virusAdvances in the development of universal influenza vaccines.Virus-like particles as universal influenza vaccinesDesign of Escherichia coli-expressed stalk domain immunogens of H1N1 hemagglutinin that protect mice from lethal challenge.
P2860
Q24614628-BF45D494-4A2F-4C0C-BB38-1281274509D5Q24630467-30B1EC2F-FEBB-4421-802B-7709E95AEFAEQ26801639-0AB36CC8-E8BD-4F89-97E6-C48ECFC9D98EQ26824545-3C4F964D-D4FE-4C13-90C2-426842527988Q27001190-0205F92A-E9EF-4949-AA76-AAA73F845FE8Q27003874-5CC35A77-6A15-48A5-92BB-655EA538A133Q27010100-B301D006-F585-4E7D-AFAE-C82668FE17D2Q27010503-3727C4FC-68FF-4803-ACBC-4D0F62115F41Q27676658-0B539244-F0C8-4F4C-BC18-89CC95A8A3C5Q27677191-4E12D0CB-4FFC-48F8-AF56-AE2B5E352F95Q28478448-716164A9-B0E0-4FE9-8F4C-ABFF3F26452CQ28539672-0F728939-845F-490D-853D-39A441007177Q30209769-572D6151-08B0-4367-BBAA-EAACB39602F3Q30224656-FBE7FA7C-CBA9-4022-9577-6B578F72AA20Q30356933-5D49AC66-39CE-42D3-A866-AAB6F69C424DQ30357665-701C1A51-6471-4CBF-8528-C0F8AB3D3F04Q30357932-1FDED1E3-8722-42FA-9126-A9FA6C89433BQ30358388-94D7C742-BAFC-48A3-99E0-E8CF0D2C4B84Q30358935-72C0F179-9B46-44FD-9A62-46DD64F71C9FQ30361950-723CB194-6870-4976-B2FE-2526DB390F30Q30362744-92933B5A-6949-468E-91E8-33C0D2D26A30Q30363190-F6ECF77B-6A2C-4DD2-B63F-2BA52DB9E1B2Q30364315-1CFE7C95-934B-4291-BFEB-32C65F982A2CQ30370445-95C08B81-114D-4CF9-B097-120C925C01ABQ30372274-D699CDF4-C255-4F2A-8655-A2FCC00FB468Q30372667-B13D311C-55BD-4AC5-9469-85817FF45DC0Q30374768-B5588320-659C-4721-BC56-4EFF059884D3Q30375268-336EAD80-D818-4A9F-8869-664C1E00C2F2Q30376605-3E721BD1-55CE-48ED-AE1D-A52E1BE3F78DQ30376724-77FF94D4-3841-4F53-A0FF-93945A97A39BQ30385071-BCA7AF02-4F5B-445A-9F55-134B30BCF1ECQ30385331-41559E5A-E3B2-45EC-A9E2-E457D95EA29FQ30386196-6372DDA4-B5C4-4EB7-8AB9-E8114765DC9CQ30389700-4CE05529-1292-4BA7-B2BB-9F382BF1CB4DQ30396399-F4A2F482-B168-4594-A1DA-B50B5A8E2240Q30400817-0BC64A99-9F62-490B-9F88-E15205D6706CQ30420210-B0D2C8FE-7276-4C3E-97D7-6BB03C80A131Q30421502-B3DDB3F2-2BF3-49DB-A2A8-74640EDABE4AQ30421558-2B798831-4940-4CD3-A8FD-E36B9C210AB8Q30421687-EB5E8F87-343B-4263-83BD-BE223BE1B485
P2860
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Design of an HA2-based Escheri ...... ice from pathogenic challenge.
@ast
Design of an HA2-based Escheri ...... ice from pathogenic challenge.
@en
type
label
Design of an HA2-based Escheri ...... ice from pathogenic challenge.
@ast
Design of an HA2-based Escheri ...... ice from pathogenic challenge.
@en
prefLabel
Design of an HA2-based Escheri ...... ice from pathogenic challenge.
@ast
Design of an HA2-based Escheri ...... ice from pathogenic challenge.
@en
P2093
P2860
P356
P1476
Design of an HA2-based Escheri ...... ice from pathogenic challenge.
@en
P2093
Cheryl Callahan
Danilo R Casimiro
Gayathri Bommakanti
Gwendolyn J Heidecker
Jan ter Meulen
John W Shiver
Joseph G Joyce
Michael P Citron
Raghavan Varadarajan
Robert W Hepler
P2860
P304
13701-13706
P356
10.1073/PNAS.1007465107
P407
P577
2010-07-06T00:00:00Z